Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Las Vegas Sands
LVS
|
+$1.33B |
| 2 |
PNC Financial Services
PNC
|
+$1.24B |
| 3 |
Uber
UBER
|
+$914M |
| 4 |
First Citizens BancShares
FCNCA
|
+$828M |
| 5 |
SW
Smurfit Westrock
SW
|
+$824M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.84B |
| 2 |
GE Aerospace
GE
|
+$1.88B |
| 3 |
CVS Health
CVS
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.45B |
| 5 |
RTX Corp
RTX
|
+$1.37B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.06% |
| 2 | Healthcare | 15.51% |
| 3 | Consumer Discretionary | 13.19% |
| 4 | Industrials | 12.43% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
IDEAYA Biosciences
IDYA
$3.56B
| $81.3M | 0.02% |
2,566,356
+401,805
| +19% | +$15.2M |
|
302
Sempra
SRE
$56.2B
| $81.2M | 0.02% |
970,538
+20,800
| +2% | +$1.66M |
|
303
International Flavors & Fragrances
IFF
$21.4B
| $79.1M | 0.02% |
753,785
| – | – |
|
304
State Street
STT
$52.2B
| $79M | 0.02% |
893,316
+16,250
| +2% | +$1.34M |
|
305
SS&C Technologies
SSNC
$18.8B
| $78.6M | 0.02% |
1,058,721
-205
| -0% | -$14.5K |
|
|
LINE
306
Lineage Inc
LINE
$9.45B
| $78.4M | 0.02% |
+1,000,000
| New | +$83.7M |
|
307
On Holding
ONON
$10.4B
| $77M | 0.02% |
1,534,451
| – | – |
|
308
SiriusPoint
SPNT
$2.66B
| $76.7M | 0.02% |
5,350,000
-200,000
| -4% | -$2.8M |
|
309
Encompass Health
EHC
$12.3B
| $76.1M | 0.02% |
787,849
| – | – |
|
310
Emerson Electric
EMR
$91.4B
| $75M | 0.02% |
685,643
+610
| +0.1% | +$65.6K |
|
311
Arthur J. Gallagher & Co
AJG
$65.5B
| $73.7M | 0.02% |
262,054
-29,297
| -10% | -$8.26M |
|
312
GSK
GSK
$101B
| $71.7M | 0.01% |
1,754,493
| – | – |
|
313
LivaNova
LIVN
$4.45B
| $71.1M | 0.01% |
1,354,088
+199,336
| +17% | +$9.88M |
|
|
BRSL
314
Brightstar Lottery PLC
BRSL
$2.08B
| $71M | 0.01% |
3,332,491
-172,547
| -5% | -$3.71M |
|
315
Noble Corp
NE
$7.04B
| $67.8M | 0.01% |
+1,877,100
| New | +$75.6M |
|
316
BridgeBio Pharma
BBIO
$16.4B
| $66.6M | 0.01% |
2,614,308
+402,223
| +18% | +$10.6M |
|
|
CSW
317
CSW Industrials
CSW
$5.65B
| $66.1M | 0.01% |
+180,461
| New | +$56.3M |
|
318
Arhaus
ARHS
$1.37B
| $65.4M | 0.01% |
5,316,406
+251,297
| +5% | +$3.39M |
|
|
AZPN
319
DELISTED
Aspen Technology Inc
AZPN
| $64.4M | 0.01% |
269,467
| – | – |
|
320
Establishment Labs
ESTA
$2.25B
| $64M | 0.01% |
1,478,041
+477,297
| +48% | +$20.8M |
|
|
SMAR
321
DELISTED
Smartsheet Inc.
SMAR
| $63.8M | 0.01% |
1,151,843
-288,532
| -20% | -$14M |
|
322
Grocery Outlet
GO
$1.01B
| $62.5M | 0.01% |
3,559,597
| – | – |
|
|
AL
323
DELISTED
Air Lease Corp
AL
| $61.6M | 0.01% |
+1,360,000
| New | +$62M |
|
324
Bristol-Myers Squibb
BMY
$130B
| $59.5M | 0.01% |
1,150,000
-191,776
| -14% | -$9M |
|
325
Camping World
CWH
$659M
| $59.3M | 0.01% |
2,447,542
| – | – |
|
Similar funds
Capital Research Global Investors's Q3 2024 Portfolio in Review
As of Q3 2024, Capital Research Global Investors held 449 positions worth $481B, up 5.6% from $456B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Capital Research Global Investors's Q3 2024 filing shows 35 new, 183 increased, 132 reduced and 34 closed positions. Its largest new stake was Smurfit Westrock: 18,121,046 shares worth $896M. The largest sale was Broadcom, an estimated $2.84B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q3 2024 buy was Smurfit Westrock: 18,121,046 shares worth $896M.
- Capital Research Global Investors added most to Las Vegas Sands in Q3 2024, an estimated $1.33B increase.
- Capital Research Global Investors's biggest Q3 2024 reduction was Broadcom, cutting an estimated $2.84B.
- Capital Research Global Investors fully exited MSCI in Q3 2024, selling an estimated $683M.
- Capital Research Global Investors's ten largest holdings make up 32% of its $481B portfolio in Q3 2024.
- Capital Research Global Investors opened 35 new positions and closed 34 in Q3 2024.
- Capital Research Global Investors's portfolio value rose 5.6% quarter-over-quarter to $481B.
Based on Capital Research Global Investors's 13F filing for Q3 2024, filed 13 Nov 2024.